Intuitive remains the dominant surgical robotics company — but other companies with savvy strategies are generating buzz and ...

Notably, Medtronic has finished enrolling patients in a U.S. study of its surgical robot, Hugo. The company is studying Hugo in patients who need hernia surgeries and benign hysterectomies.

Medtronic is nearing a U.S. launch for its Hugo surgical robot more than three years after receiving approval to release the soft tissue system in Europe. CEO Geoff Martha told investors Tuesday ...

Medtronic’s potential rivalry in US market Medtronic’s Hugo robot poses the main challenge to da Vinci given the company's size. Hugo has been in use in Europe since 2022 and the company ...

Discover why Intuitive Surgical's monopoly-like position is under threat from emerging competitors like Medtronic and J&J.

Medtronic is making major moves with its Hugo surgical robot platform to submit for the FDA approval in 2025. MDT currently trails Intuitive Surgical in this niche, but the roll-out of the Hugo ...

the Hugo System, for an area that remains deeply underpenetrated. Both of these niches could represent powerful, long-term tailwinds for the company. Furthermore, Medtronic is implementing ...

Recent gains from Medtronic (MDT -7%) are being cut into today despite the ... MDT noted that utilization is continuing to increase overseas, with Hugo procedure volumes doubling yr/yr. Hugo is MDT's ...